Skip to main content
Signal8

KRANZLER JAY D

SEC insider (Form 3/4/5 filer). CIK 0001055666. Director at AVENUE THERAPEUTICS, INC. (ATXI). 4 reported Form 4/5 transactions since Sep 2024; latest on Nov 5, 2024. Located in BAY HARBOR ISLANDS, FL.

Companies KRANZLER JAY D has filed insider reports for

  • AVENUE THERAPEUTICS, INC. (ATXI): Director
KRANZLER JAY D profile photo

KRANZLER JAY D

CIK: 0001055666

Transaction Breakdown

Open Market Buys (P)2 (50.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

AVENUE THERAPEUTICS, INC. logo
ATXI

AVENUE THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • AVENUE THERAPEUTICS, INC. logo
    ATXI

    AVENUE THERAPEUTICS, INC.

    Nov 5, 2024
    Sale
    Direct
    61 shares at avg. $2.24$136.64
  • AVENUE THERAPEUTICS, INC. logo
    ATXI

    AVENUE THERAPEUTICS, INC.

    Sep 30, 2024
    Purchase
    Direct
    497 shares at avg. $2.50$1K
  • AVENUE THERAPEUTICS, INC. logo
    ATXI

    AVENUE THERAPEUTICS, INC.

    Sep 27, 2024
    Purchase
    Direct
    3 shares at avg. $2.40$7.2
  • AVENUE THERAPEUTICS, INC. logo
    ATXI

    AVENUE THERAPEUTICS, INC.

    Sep 23, 2024
    Award

    Employee stock option (right to buy)

    Direct
    30K shares-

1-4 of 4